| Name | (2S)-2-[(2,6-difluorobenzoyl)amino]-3-[4-[4-(ethoxymethyl)-2,6-dimethoxyphenyl]phenyl]propanoic acid |
|---|---|
| Synonyms |
Firategrast (USAN)
Firategrast UNII-OJY3SK9H5F |
| Description | Firategrast is an orally bioavailable α4β1/α4β7 integrin antagonist. |
|---|---|
| Related Catalog | |
| Target |
α4β1/α4β7[1] |
| In Vitro | Firategrast is an orally bioavailable α4β1/α4β7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS)[1]. |
| References |
| Molecular Formula | C27H27F2NO6 |
|---|---|
| Molecular Weight | 499.50300 |
| Exact Mass | 499.18100 |
| PSA | 97.58000 |
| LogP | 5.18600 |
| Storage condition | 2-8℃ |